Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Bulgarian patients blame state policy for poor access to medicines

This article was originally published in RAJ Devices

Executive Summary

Within the last 12 months, almost 18% of Bulgarian patents stopped taking prescribed medicines, citing financial reasons. A further 70% believe that drug expenditure incurred during treatment is a significant burden for their personal budgets. According to a recent poll carried out by consultancy Gallup International, Bulgarian patients are deeply unhappy with the healthcare policy carried out by the government and believe that state expenditure in this area should be increased.

Latest Headlines
See All
UsernamePublicRestriction

Register

SC092918

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel